Clinical Trial: Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole: A Dose Escalation Study of Efficacy and Tolerability

Brief Summary: The purpose of this study is to evaluate the use of the non-ergoline dopamine agonist ropinirole for the treatment of hyperprolactinemia in patients with idiopathic hyperprolactinemia and prolactinomas.